FORT LAUDERDALE, FL, May 07, 2018 (GLOBE NEWSWIRE) -- MediXall Group Inc., (OTCQB: MDXL), a technology and innovation-driven organization structured to bring effective change to the U.S. Healthcare Industry, today announced the appointment of Dr. Christopher Metzler as a non-executive director.
“We are very pleased to have Dr. Metzler join our board and look forward to his contributions,” said Michael Swartz, President of MediXall. “Dr. Metzler is a global thought leader, and he understands the power we have to reimagine the way healthcare providers can do business. His experience as an entrepreneur, government strategist, and industry disruptor will be invaluable to MediXall and our customers in this new digital healthcare environment.”
Dr. Christopher Metzler is a political pundit, international strategist, legal scholar, and serial entrepreneur/CEO to a worldwide medical empire. An on-camera television and digital personality, he is best known for going beyond the talking points with in-depth reasoning, modern-day voice, and analysis. During regular appearances on CNN, ABC, MSNBC, Fox News, Al Jazeera, HLN, Newsmax, CNBC, OAN, WHDT TV, BBC, TV ONE, News One, Arise America, Celebrity Page TV, Afterbuzz and more, he provides expert commentary on U.S. and global affairs, politics, healthcare, trending topics, and law.
According to Dr. Metzler, “Healthcare is of concern to all Americans. The costs have skyrocketed, yet care has diminished. I am humbled to join the MediXall Board because I believe that MediXall will disrupt the healthcare sector by providing access to exceptional providers at competitive prices. I am looking forward to lending my expertise to their innovative team to revolutionize healthcare for all.”
Educated at The University of Oxford in Oxford, England and Columbia University, Dr. Metzler obtained a Ph.D. in International Legal Philosophy and Medicine from The University of Aberdeen. A former faculty member at Cornell University, he was both a professor and Senior Associate Dean of Applied Management Degrees at Georgetown University. Today, he is a Senior Fellow at Thomas Jefferson University’s Institute of Emerging Health Professions — home of The Sidney Kimmel School of Medicine.
A seasoned, conservative political operative, Dr. Metzler has worked on major political campaigns providing appropriate messaging and strategic advice as a direct link to the governing party as well as the Republican party.
“Drawing on his years of experience in healthcare and politics, Dr. Metzler will provide fresh insight to our technology, business, and political priorities. We continue to transform our business and the healthcare industry as a whole at an accelerated pace,” said MediXall Group Chief Executive Officer Neil Swartz.
Since the start of his career in 1992, as a Legal and Medical Scholar, Dr. Metzler has worked in over twenty countries providing advice on geopolitics, emerging markets, world law, medicine and related topics. Dr. Metzler’s business portfolio spans wide in the medical and management consulting fields. Currently, he is a Director/CEO of Gordium Healthcare, City Place Pharmacy, Next Generation Labs, Southern Medical Labs of NW Florida, JMI Consulting, Medicine on Wheels, 911 Urgent Care, FHWFIT, and others.
For more information, please visit MediXallGroup.com or call (954) 440-4678.
About MediXall Healthcare Marketplace: The MediXall Healthcare Marketplace is a new generation healthcare marketplace platform designed to address the growing need of self-pay and high deductible consumers for greater transparency and price competition in their healthcare costs. With MediXall, consumers now have the option to search for doctors or dentists and book appointments based on cost, distance, ratings, and availability at the click of a button. By delivering a solution that better connects consumers with high-quality healthcare providers and wellness services, MediXall enables healthcare providers to engage consumers with a level of price transparency and digital convenience that they have come to expect in every other aspect of their lives. In this era of rapidly increasing deductibles and healthcare costs, the cloud-based platform is designed to be transformational and disruptive to traditional methods of medical care and provisioning of medical services to the consumer.
About MediXall Group, Inc.: MediXall Group is a technology and innovation-driven organization purposefully designed and structured to bring effective change to the U.S. healthcare industry that is actively trading on the OTCQB under the symbol “MDXL.” The Company believes its revolutionary approach will help drive much-needed change that it envisions is needed in the current healthcare system. The mission of the MediXall Group is to revolutionize the medical industry by improving communication; providing better technology and support services; and enabling more efficient, cost-effective healthcare for the consumer. By approaching the healthcare ecosystem as a whole, MediXall creates, invests and incubates companies that embody its mission statement.
Safe Harbor Statement: This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the Company’s current plans and expectations, as well as future results of operations and financial condition. Specifically, the Company’s ability to raise additional capital, execute its business plan and strategy, sustain or increase gross margins, achieve profitability and build shareholder value are forward-looking statements. A more extensive listing of risks and factors that may affect the Company’s business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the Company with the Securities and Ex-change Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.